{
    "title": "U.S. FDA staff flags unclear benefits of Ardelyx's kidney disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11426531/U-S-FDA-staff-flags-unclear-benefits-Ardelyxs-kidney-disease-drug.html",
    "date": "2022-11-14",
    "keywords": [
        "drug",
        "kidney",
        "disease",
        "staff",
        "monday",
        "tenapanor",
        "blood",
        "year",
        "phosphorus",
        "food",
        "administration",
        "approval",
        "magnitude",
        "treatment",
        "effect",
        "line",
        "tone",
        "discussion",
        "wednesday",
        "analyst",
        "client",
        "note",
        "phosphate",
        "ckd",
        "ardelyx",
        "plc",
        "meeting",
        "nov16",
        "fda",
        "appeal",
        "rejection",
        "july",
        "therapy",
        "hyperphosphatemia",
        "condition",
        "level",
        "sign",
        "damage",
        "calcium",
        "body",
        "turn",
        "muscle",
        "skin",
        "government",
        "report",
        "reporting",
        "khushi",
        "mandowara",
        "leo",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}